Localized striatal delivery of GDNF as a treatment for Parkinson disease

被引：223

作者：

Kirik, D ^{[1
]}

Georgievska, B ^{[1
]}

Björklund, A ^{[1
]}

机构：

[1] Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden

来源：

NATURE NEUROSCIENCE | 2004年 / 7卷 / 02期

关键词：

D O I：

10.1038/nn1175

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：105 / 110

页数：6

共 50 条

[1] Recombinant proteins for neurodegenerative diseases: the delivery issue [J].

Aebischer, P ;

Ridet, JL .

TRENDS IN NEUROSCIENCES, 2001, 24 (09) :533-540

[2] Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects [J].

Ai, Y ;

Markesbery, W ;

Zhang, ZM ;

Grondin, R ;

Elseberry, D ;

Gerhardt, GA ;

Gash, DM .

JOURNAL OF COMPARATIVE NEUROLOGY, 2003, 461 (02) :250-261

[3] Lentiviral vectors as a gene delivery system in the mouse midbrain:: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF [J].

Bensadoun, JC ;

Déglon, N ;

Tseng, JL ;

Ridet, JL ;

Zurn, AD ;

Aebischer, P .

EXPERIMENTAL NEUROLOGY, 2000, 164 (01) :15-24

[4] Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model [J].

Björklund, A ;

Kirik, D ;

Rosenblad, C ;

Georgievska, B ;

Lundberg, C ;

Mandel, RJ .

BRAIN RESEARCH, 2000, 886 (1-2) :82-98

[5] Dopaminergic neurons protected from degeneration by GDNF gene therapy [J].

ChoiLundberg, DL ;

Lin, Q ;

Chang, YN ;

Chiang, YL ;

Hay, CM ;

Mohajeri, H ;

Davidson, BL ;

Bohn, MC .

SCIENCE, 1997, 275 (5301) :838-841

[6] Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat [J].

Connor, B ;

Kozlowski, DA ;

Schallert, T ;

Tillerson, JL ;

Davidson, BL ;

Bohn, MC .

GENE THERAPY, 1999, 6 (12) :1936-1951

[7] Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets [J].

Costa, S ;

Iravani, MM ;

Pearce, RKB ;

Jenner, P .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (01) :45-50

[8] Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease [J].

Déglon, N ;

Tseng, JL ;

Bensadoun, JC ;

Zurn, AD ;

Arsenijevic, Y ;

De Almeida, LP ;

Zufferey, R ;

Trono, D ;

Aebischer, P .

HUMAN GENE THERAPY, 2000, 11 (01) :179-190

[9] Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys [J].

Gash, DM ;

Zhang, ZM ;

Cass, WA ;

Ovadia, A ;

Simmerman, L ;

Martin, D ;

Russell, D ;

Collins, F ;

Hoffer, BJ ;

Gerhardt, GA .

JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 363 (03) :345-358

[10] Functional recovery in parkinsonian monkeys treated with GDNF [J].

Gash, DM ;

Zhang, ZM ;

Ovadia, A ;

Cass, WA ;

Yi, A ;

Simmerman, L ;

Russell, D ;

Martin, D ;

Lapchak, PA ;

Collins, F ;

Hoffer, BJ ;

Gerhardt, GA .

NATURE, 1996, 380 (6571) :252-255

← 1 2 3 4 5 →